CAPTEM treatment for neuroendocrine tumor

Efficacy of CAPTEM treatment for unresectable neuroendocrine tumor - Efficacy of CAPTEM treatment for unresectable neuroendocrine tumor

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031180261

Enrollment

Registered

2019-03-13

Start date

2016-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Performance status 0 or 1, no severe renal, heart, lung and liver dysfunction Neuroendocrine Tumors

Interventions

drug therapy

Q000188

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Unresecrable neuroendocrine tumor

Exclusion criteria

Exclusion criteria: Other treatment was stopped before 4 weeks and surgical resection was stopped before 3 months

Design outcomes

Primary

Measure	Time frame
Response rate	—

Secondary

Measure	Time frame
Progression free survival, overall survival, adverse event	—

Contacts

Public ContactNoritoshi Kobayashi

Yokohama City University Hospital

norikoba@yokohama-cu.ac.jp+81-45-787-2623

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026